NRP/543 Week 8: Comprehensive Pediatric Case, sample paper

A Family Plan, Not a Diet: Evaluating and Treating Obesity in a 10-Year-Old Girl Under the 2023 Pediatric Guideline, From Comorbidity Screening to Intensive Health Behavior and Lifestyle Treatment

[Student Name]

University of Phoenix

NRP/543: Management of Pediatric and Adolescent Populations

Week 8 Assignment

[Instructor Name]

[Date]

The child and family are composites written for a model paper.

Isabella, a 10-year-old girl, comes with her mother for a well-child visit. Her BMI is 27.4, above the 97th percentile for her age and sex, and 115% of the 95th percentile. Her BMI has risen steadily since age six. Her mother, who also has obesity, asks whether Isabella should "go on a diet." What follows is how the visit unfolded and what we decided together.

The Problem in Context

Obesity in U.S. children has not declined; an analysis of national data from 1999 to 2016 found no evidence of a decrease in obesity prevalence at any age and a rise in severe obesity among young children (Skinner et al., 2018). Obesity in childhood tends to persist into adulthood and brings risks of type 2 diabetes, fatty liver disease, hypertension, sleep apnea, orthopedic problems and depression.

Measuring and Classifying

The American Academy of Pediatrics defines obesity as a BMI at or above the 95th percentile and severe obesity as at or above 120% of the 95th percentile (Hampl et al., 2023). Isabella has obesity, approaching the severe range. I confirm the measurements with a calibrated scale and stadiometer and plot them on the growth chart with the family, so they can see the trend.

Language and Stigma

The guideline emphasizes nonstigmatizing, person-first language and a family-centered approach (Hampl et al., 2023). I ask permission before discussing weight, speak of "health" and "a weight that is healthy for your body" rather than labels and avoid blaming Isabella or her mother. I ask Isabella what she enjoys and what she would like to be able to do more easily; she says she wants to keep up with friends at recess.

The guideline asks the clinician to treat obesity as a chronic disease in a family, not a failure of willpower in a child.

History

Diet: sweetened drinks at most meals, fast food three times a week, few vegetables, a large after-school snack. Activity: 30 minutes of recess, no organized sports, about four hours of screen time daily. Sleep: 8 hours, with a phone in her bedroom. Family: both parents work, the neighborhood lacks safe parks, and her grandmother, who cares for her after school, uses food as a reward. Psychosocial: Isabella reports being teased at school; a brief depression screen is negative but she feels "sad sometimes" about her body. Symptoms: occasional snoring, no daytime sleepiness, no joint pain, no headaches. Menarche has not occurred.

Examination

Blood pressure 116/74 mm Hg, which falls in the elevated range when plotted against the tables for a girl of her age and height. Acanthosis nigricans on the neck, a sign of insulin resistance. No goiter, no striae suggesting cortisol excess and no features of a genetic syndrome. Tonsils not enlarged. Normal hip and knee examination. Tanner stage 2.

Comorbidity Screening

The guideline recommends evaluation for comorbidities in children 10 and older with obesity, including a lipid panel, fasting glucose or A1C and alanine aminotransferase for fatty liver disease (Hampl et al., 2023). Isabella's results: A1C 5.9%, in the prediabetes range; a triglyceride level of 168 and an HDL level of 38, both outside the healthy range for her age; alanine aminotransferase 42 U/L, mildly elevated. The Endocrine Society guideline advises against routine endocrine testing for obesity unless growth is slowing or other signs suggest an endocrine cause (Styne et al., 2017); Isabella's height is growing normally, so thyroid and cortisol testing are not needed.

Assessment

Obesity, approaching severe, with prediabetes, dyslipidemia, elevated blood pressure, possible fatty liver disease and weight-related teasing.

Treatment: Intensive Health Behavior and Lifestyle Treatment

The most effective behavioral option in the guideline is an intensive, family-based program combining nutrition, activity and behavior support, with at least 26 hours of in-person contact spread over three to 12 months (Hampl et al., 2023). I refer the family to such a program at the children's hospital, which offers sessions in Spanish and English. The guideline also advises against "watchful waiting," since obesity tends to worsen without treatment.

Changes to Start Now

While awaiting the program, we agree on three family goals: water or low-fat milk instead of sweetened drinks for everyone, a family walk or active play after dinner four days a week and moving the phone out of the bedroom at night. I suggest the grandmother use praise or activities rather than food as rewards, and I invite her to the next visit.

Why Not a Diet

Her mother's question about a diet deserves a direct answer. Restrictive diets for children can reduce growth-supporting nutrition, increase preoccupation with food and raise the risk of disordered eating, particularly in a child already teased about her body. The family-based approach changes what is available and what everyone does, so Isabella is not singled out, and the whole family's health benefits. I explained that her mother and father would also be part of the program.

Sleep and Screens

Short sleep and late-night screen use are linked to weight gain in children, through effects on appetite hormones, snacking and reduced activity. Moving the phone out of the bedroom and setting a regular bedtime are small, concrete changes that support the rest of the plan.

The Liver Result

Isabella's mildly raised alanine aminotransferase suggests fatty liver disease, which is common in children with obesity. The guideline recommends repeat testing and, if elevation persists, further evaluation (Hampl et al., 2023). Weight stabilization and improved diet often lower the level.

Medication and Surgery

The guideline recommends offering pharmacotherapy to adolescents 12 and older with obesity as an adjunct to lifestyle treatment and considering metabolic surgery for adolescents 13 and older with severe obesity (Hampl et al., 2023). Isabella is 10, so these are not options now, but I will revisit them as she grows if needed.

Teasing and Mental Health

I ask the family's permission to contact the school counselor about the teasing. Weight stigma worsens both mental health and eating behaviors, and addressing it is part of treatment.

Measuring Success

Success will not be measured by weight alone. Stabilizing BMI while she grows taller, lowering her A1C out of the prediabetes range, improving her lipids and blood pressure and, just as important, Isabella feeling better about herself and keeping up at recess are the outcomes that matter.

Follow-Up

Monthly visits during the first three months, with repeat blood pressure, weight, and a review of goals. Repeat A1C, lipids and alanine aminotransferase in three to six months.

Conclusion

Isabella has obesity with prediabetes, dyslipidemia, elevated blood pressure and possible fatty liver disease, found through the comorbidity screening the 2023 guideline recommends. A family-centered, nonstigmatizing approach, referral to intensive health behavior and lifestyle treatment and three shared family goals follow the guideline's recommendations for a 10-year-old, with medication reserved for later if needed. The plan treats obesity as a chronic condition of the family's environment, not a diet for one child.

References

Hampl, S. E., Hassink, S. G., Skinner, A. C., Armstrong, S. C., Barlow, S. E., Bolling, C. F., Avila Edwards, K. C., Eneli, I., Hamre, R., Joseph, M. M., Lunsford, D., Mendonca, E., Michalsky, M. P., Mirza, N., Ochoa, E. R., Sharifi, M., Staiano, A. E., Weedn, A. E., Flinn, S. K., . . . Okechukwu, K. (2023). Clinical practice guideline for the evaluation and treatment of children and adolescents with obesity. Pediatrics, 151(2), Article e2022060640. https://doi.org/10.1542/peds.2022-060640

Skinner, A. C., Ravanbakht, S. N., Skelton, J. A., Perrin, E. M., & Armstrong, S. C. (2018). Prevalence of obesity and severe obesity in US children, 1999-2016. Pediatrics, 141(3), Article e20173459. https://doi.org/10.1542/peds.2017-3459

Styne, D. M., Arslanian, S. A., Connor, E. L., Farooqi, I. S., Murad, M. H., Silverstein, J. H., & Yanovski, J. A. (2017). Pediatric obesity: Assessment, treatment, and prevention: An Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 102(3), 709-757. https://doi.org/10.1210/jc.2016-2573